[04/10/14]
Posted on April 10, 2014 in Health Information Technology
Written by: Mark R. Dahlby
On April 3, 2014, the U.S. Food and Drug Administration (“FDA”), the Office of the National Coordinator for Health Information Technology (“ONC”) and the Federal Communications Commission (“FCC”) released their long-awaited final report on health information technology (“Health IT”), entitled Proposed Strategy and Recommendations for a Risk-Based Framework. According to the report, the degree... READ MORE
Tags: FDA
[03/28/13]
Posted on March 28, 2013 in Health Information Technology
Written by: Mark R. Dahlby
On March 12, the Federal Trade Commission (“FTC”) published new guidance detailing how advertising disclosures should be made online. Disclosures are necessary to qualify or limit advertising claims that would otherwise be deceptive, unfair or give misleading impressions. READ MORE
Tags: FCC, FDA, Mobile apps, Mobile Devices, Mobile Medical Apps, Social Media
[03/01/13]
Posted on March 1, 2013 in Long-Term Care, Home Health & Hospice
Written by: Kendra Conover
The Food and Drug Administration (“FDA”) is seeking comments on a draft guidance entitled “Design Considerations for Devices Intended for Home Use.” The draft guidance urges manufacturers to “design out” product risks and consider usability and training for medical devices intended for use in a home environment. The deadline for submitting comments on the... READ MORE
Tags: conover, FDA, Home Health, selby
[02/22/13]
Posted on February 22, 2013 in Health Information Technology
Written by: Mark R. Dahlby
ECRI Institute has released its list of the Top 10 Health Technology Hazards for 2013. The annual report is based on the prevalence and severity of incidents reported by health care facilities and information found in the Institute’s medical device problem reporting databases. READ MORE
Tags: Data Management, EHRs, FDA, IT, Meaningful Use, Mobile apps, Mobile Devices, Mobile Medical Apps, Patient Safety
[12/07/11]
Posted on December 7, 2011 in Long-Term Care, Home Health & Hospice
Written by: Selby, Todd J.
On November 30, 2011, Daniel R. Levinson, Inspector General, appeared before the Special Committee on Aging, and testified regarding the Office of Inspector General’s (OIG) findings pertaining to the use of atypical antipsychotic drugs by nursing home residents. The OIG hired psychiatrists who are experts in treating elderly patients to review a sample of... READ MORE
Tags: antipsychotic, bufford, cms, drugs, elderly, FDA, hall render, inspector general, jent, Litigation and Risk Management, long term care, lvinson, Medicare, medication, nursing home, oig, resident, selby, snf
